Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guilin Sanjin Pharmaceutical is one of China's largest producers of traditional Chinese medicine and herbal lozenges with over fifty years of history and more than two hundred registered medicines on market—best known for its watermelon frost lozenges and tablets targeting throat/oral health and urinary tract conditions. The company has strong R&D capabilities with state-recognized technology centers. Harbin Pharm. Group Sanjin develops both western pharmaceuticals and TCMs including several approved small molecule drugs such as omacetaxine mepesuccinate (approved in US), sertraline citrate, quinapril hydrochloride—targeting cancer/myelodysplastic syndromes, psychiatric disorders/OCD, cardiovascular disease/hypertension respectively.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanjing.